tiprankstipranks
Trending News
More News >
Firebrick Pharma Limited (AU:FRE)
ASX:FRE
Australian Market
Advertisement

Firebrick Pharma Limited (FRE) Stock Statistics & Valuation Metrics

Compare
7 Followers

Total Valuation

Firebrick Pharma Limited has a market cap or net worth of ―. The enterprise value is AU$12.77M.
Market Cap
Enterprise ValueAU$12.77M

Share Statistics

Firebrick Pharma Limited has 250,371,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding250,371,370
Owned by Insiders
Owned by Institutions

Financial Efficiency

Firebrick Pharma Limited’s return on equity (ROE) is -1.69 and return on invested capital (ROIC) is -168.60%.
Return on Equity (ROE)-1.69
Return on Assets (ROA)-1.44
Return on Invested Capital (ROIC)-168.60%
Return on Capital Employed (ROCE)-1.84
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover0.16
Inventory Turnover0.97

Valuation Ratios

The current PE Ratio of Firebrick Pharma Limited is ―. Firebrick Pharma Limited’s PEG ratio is -0.06.
PE Ratio
PS Ratio44.43
PB Ratio8.38
Price to Fair Value8.38
Price to FCF-7.00
Price to Operating Cash Flow-8.49
PEG Ratio-0.06

Income Statement

In the last 12 months, Firebrick Pharma Limited had revenue of 293.42K and earned -2.63M in profits. Earnings per share was -0.01.
Revenue293.42K
Gross Profit104.82K
Operating Income-2.87M
Pretax Income-2.63M
Net Income-2.63M
EBITDA-2.86M
Earnings Per Share (EPS)-0.01

Cash Flow

In the last 12 months, operating cash flow was -1.18M and capital expenditures -16.50K, giving a free cash flow of -1.20M billion.
Operating Cash Flow-1.18M
Free Cash Flow-1.20M
Free Cash Flow per Share>-0.01

Dividends & Yields

Firebrick Pharma Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.65
52-Week Price Change16.67%
50-Day Moving Average0.07
200-Day Moving Average0.07
Relative Strength Index (RSI)52.69
Average Volume (3m)55.87K

Important Dates

Firebrick Pharma Limited upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date

Financial Position

Firebrick Pharma Limited as a current ratio of 5.47, with Debt / Equity ratio of 0.00%
Current Ratio5.47
Quick Ratio4.75
Debt to Market Cap0.00
Net Debt to EBITDA0.34
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Firebrick Pharma Limited has paid -222.09K in taxes.
Income Tax-222.09K
Effective Tax Rate0.08

Enterprise Valuation

Firebrick Pharma Limited EV to EBITDA ratio is -4.22, with an EV/FCF ratio of -6.47.
EV to Sales41.08
EV to EBITDA-4.22
EV to Free Cash Flow-6.47
EV to Operating Cash Flow-6.78

Balance Sheet

Firebrick Pharma Limited has AU$983.35K in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$983.35K billion.
Cash & Marketable SecuritiesAU$983.35K
Total DebtAU$0.00
Net CashAU$983.35K
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01

Margins

Gross margin is 63.41%, with operating margin of -976.65%, and net profit margin of -897.83%.
Gross Margin63.41%
Operating Margin-976.65%
Pretax Margin-897.83%
Net Profit Margin-897.83%
EBITDA Margin-973.71%
EBIT Margin-976.65%

Analyst Forecast

The average price target for Firebrick Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast1920.53%
EPS Growth Forecast-89.39%

Scores

Smart Score3
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis